Virtu Financial LLC Biomarin Pharmaceutical Inc Transaction History

Virtu Financial LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$82.16 - $96.94 $868,842 - $1.03 Million	10,575 New	10,575 $896,000
Q2 2022 Aug 09, 2022	SELL	$71.48 - $86.85 $866,480 - $1.05 Million	-12,122 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$74.28 - $92.69 $900,422 - $1.12 Million	12,122 New	12,122 $935,000
Q4 2021 Feb 17, 2022	SELL	$71.72 - $91.47 $265,364 - $338,439	-3,700 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$74.77 - $85.47 $276,649 - $316,239	3,700 New	3,700 $286,000
Q4 2020 Feb 24, 2021	SELL	$72.61 - $90.2 $1.31 Million - $1.63 Million	-18,026 Closed	0 $0
Q3 2020 Dec 11, 2020	BUY	$71.87 - $131.03 $1.3 Million - $2.36 Million	18,026 New	18,026 $1.37 Million
Q4 2019 Feb 04, 2020	SELL	$64.27 - $86.37 $498,670 - $670,144	-7,759 Closed	0 $0
Q3 2019 Nov 20, 2019	BUY	$67.4 - $85.11 $522,956 - $660,368	7,759 New	7,759 $523,000
Q2 2019 Aug 13, 2019	SELL	$80.35 - $93.9 $1.13 Million - $1.32 Million	-14,015 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$84.2 - $98.62 $844,441 - $989,059	10,029 Added 251.61%	14,015 $1.25 Million
Q4 2018 Jan 16, 2019	SELL	$80.14 - $106.07 $265,103 - $350,879	-3,308 Reduced 45.35%	3,986 $339,000
Q3 2018 Nov 13, 2018	BUY	$93.92 - $105.72 $685,052 - $771,121	7,294 New	7,294 $707,000
Q1 2018 May 14, 2018	SELL	$77.67 - $92.63 $234,485 - $279,649	-3,019 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$80.76 - $95.13 $92,550 - $109,018	-1,146 Reduced 27.52%	3,019 $269,000
Q3 2017 Nov 15, 2017	BUY	$80.6 - $94.95 $335,699 - $395,466	4,165	4,165 $388,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.